Siriraj Hospital‘s Faculty of Medicine, underneath Mahidol University, is partnering with native synthetic intelligence (AI) start-up, Cariva (Thailand), to utilise AI know-how in enhancing medical treatment and developing progressive medical services and products. This collaboration is aimed at solidifying Thailand’s status as a medical hub and facilitating the export of AI-driven healthcare innovations to the Asia-Pacific region.
Dr Apichat Asavamongkolkul, the college dean on the hospital, underscored the potential of AI during the memorandum of understanding signed with Cariva. Apichat believes that the mixing of AI into their services can help handle a shortage of physicians, enhance diagnostic accuracy, and enhance medical remedy by offering personalised care. The partnership also envisages nurturing medical AI and medtech start-ups.
Dr Cherdchai Nopmaneejumruslers, the deputy dean for service innovation and organisational values, asserted that the venture would contribute to strengthening the AI medical ecosystem in Thailand. By automating certain duties, AI can assist medical staff who are burdened with extreme workloads.
The collaboration encompasses 4 projects, including the creation of SiCAR Ai Lab, a platform for testing and developing medical AI. This lab will present Thai start-ups with the opportunity to develop extra efficient medical AI, bettering well being diagnosis outcomes and reinforcing the medical AI ecosystem.
The second venture entails Mahidol University’s Radiology Department creating RAD Scan AI, capable of reading and analysing images such as tumours. This AI, developed by Cariva, can measure the mass of organs and tumours and generate 3D pictures, thus lowering preparation time for medical staff.
Siwadol Matayakul, the CEO and co-founder of Cariva (Thailand) Co, acknowledged that the partnership with Siriraj would help the commercialisation of their product in the market. He added that the RAD Scan AI, developed using overseas information, can be tailored to higher go nicely with the information of native sufferers.
Insider involves the Siriraj Genomics Centre launching new products, together with NanoPGx, a nanopore-based pharmacogenomics offering. This high-precision course of can analyse genes with potential for medicine allergy symptoms on a population-independent basis, making it suitable for both locals and foreigners.
Lastly, the Center for Value Driven Care (VDC), an R&D centre owned by the college, goals to develop innovation and link information from Siriraj medical experience with new technological advances. This centre can broaden to include AI medical incubation and accelerator programmes.
Cariva, which counts AI and Robotics Ventures Co Ltd (ARV), a subsidiary of PTT Exploration and Production, as an investor, aims to turn out to be a unicorn start-up by 2028, reported Bangkok Post.
Follow The Thaiger’s latest tales on our new Facebook web page: CLICK HERE..
Your point of view caught my eye and was very interesting. Thanks. I have a question for you.
Your point of view caught my eye and was very interesting. Thanks. I have a question for you.
Can you be more specific about the content of your article? After reading it, I still have some doubts. Hope you can help me.
Thank you for your sharing. I am worried that I lack creative ideas. It is your article that makes me full of hope. Thank you. But, I have a question, can you help me?